Literature DB >> 31063750

EMT and Cancer: More Than Meets the Eye.

Rik Derynck1, Robert A Weinberg2.   

Abstract

Epithelial cells acquire mesenchymal characteristics during development, wound healing and inflammation, and in cancer and fibrosis. With increasing appreciation of different roles of epithelial-mesenchymal transition (EMT), we address the question of how to define and recognize EMT processes and discuss their properties in cancer progression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31063750      PMCID: PMC7672963          DOI: 10.1016/j.devcel.2019.04.026

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  16 in total

1.  Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition.

Authors:  Yoko Katsuno; Dominique Stephan Meyer; Ziyang Zhang; Kevan M Shokat; Rosemary J Akhurst; Kohei Miyazono; Rik Derynck
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

Review 2.  A common framework for EMT and collective cell migration.

Authors:  Kyra Campbell; Jordi Casanova
Journal:  Development       Date:  2016-12-01       Impact factor: 6.868

3.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration.

Authors:  Nicole M Aiello; Ravikanth Maddipati; Robert J Norgard; David Balli; Jinyang Li; Salina Yuan; Taiji Yamazoe; Taylor Black; Amine Sahmoud; Emma E Furth; Dafna Bar-Sagi; Ben Z Stanger
Journal:  Dev Cell       Date:  2018-06-18       Impact factor: 12.270

4.  Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas.

Authors:  Anushka Dongre; Mohammad Rashidian; Ferenc Reinhardt; Aaron Bagnato; Zuzana Keckesova; Hidde L Ploegh; Robert A Weinberg
Journal:  Cancer Res       Date:  2017-04-20       Impact factor: 12.701

5.  Slug and Sox9 cooperatively determine the mammary stem cell state.

Authors:  Wenjun Guo; Zuzana Keckesova; Joana Liu Donaher; Tsukasa Shibue; Verena Tischler; Ferenc Reinhardt; Shalev Itzkovitz; Aurelia Noske; Ursina Zürrer-Härdi; George Bell; Wai Leong Tam; Sendurai A Mani; Alexander van Oudenaarden; Robert A Weinberg
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

Review 6.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

Review 7.  Therapy resistance mediated by cancer stem cells.

Authors:  Teresa Bernadette Steinbichler; József Dudás; Sergej Skvortsov; Ute Ganswindt; Herbert Riechelmann; Ira-Ida Skvortsova
Journal:  Semin Cancer Biol       Date:  2018-11-22       Impact factor: 15.707

Review 8.  Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

Authors:  Shomyseh Sanjabi; Soyoung A Oh; Ming O Li
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

Review 9.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

Review 10.  EMT Transition States during Tumor Progression and Metastasis.

Authors:  Ievgenia Pastushenko; Cédric Blanpain
Journal:  Trends Cell Biol       Date:  2018-12-26       Impact factor: 20.808

View more
  88 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

2.  HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.

Authors:  Zhi-Xi Li; Gang Wu; Wen-Jun Jiang; Jie Li; You-Yu Wang; Xue-Ming Ju; Yan-Tao Yin
Journal:  Cell Cycle       Date:  2019-12-26       Impact factor: 4.534

3.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 4.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 5.  Tumor Plasticity and Resistance to Immunotherapy.

Authors:  Lucas A Horn; Kristen Fousek; Claudia Palena
Journal:  Trends Cancer       Date:  2020-03-04

6.  Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion.

Authors:  Megan E Martin; Denise K Reaves; Breanna Jeffcoat; Jeffrey R Enders; Lindsey M Costantini; Susan T Yeyeodu; Diane Botta; Terrance J Kavanagh; Jodie M Fleming
Journal:  Nanomedicine       Date:  2019-07-24       Impact factor: 5.307

Review 7.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

Review 8.  EMT, MET, Plasticity, and Tumor Metastasis.

Authors:  Basil Bakir; Anna M Chiarella; Jason R Pitarresi; Anil K Rustgi
Journal:  Trends Cell Biol       Date:  2020-08-13       Impact factor: 20.808

Review 9.  Protein tyrosine kinase 6 signaling in prostate cancer.

Authors:  Wanian M Alwanian; Angela L Tyner
Journal:  Am J Clin Exp Urol       Date:  2020-02-25

Review 10.  Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression.

Authors:  Kristen Fousek; Lucas A Horn; Claudia Palena
Journal:  Pharmacol Ther       Date:  2020-09-24       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.